Prostate cancer synchronously or metachronously metastasizing to the testis is a rare finding. We herein report on the first case of a solitary testicular metastasis from an organ-confined prostate cancer, diagnosed 6 months after a radical prostatectomy, without evidence of previous or concomitant biochemical and local recurrence.
Introduction
Testicular metastases of carcinoma are a rare finding, with approximately 200 reported cases, and the most common location of the primary tumour is prostate, lung and gastrointestinal tract. 1 Testicular involvement from prostate cancer, which has been described in less than 80 patients, is thought to occur through the vas deferens or via lymphatic spread and is associated with an advanced stage of disease, being usually incidentally discovered at bilateral orchiectomy or at autopsy. 2 To the best of our knowledge, prostate carcinoma recurrent to the testis after radical treatment of the primary tumour has been reported only once, simultaneously with local relapse. 3 We herein, present the first case of a solitary testicular metastasis from an organ-confined prostate cancer, diagnosed 6 months after a radical prostatectomy, without evidence of previous or concomitant biochemical and local recurrence.
Case report
A 67-year-old man was referred to our outpatient clinic with complaints of LUTS and a slowly growing scrotal swelling. Physical examination revealed a tender, transilluminable mass within the left scrotum with normal testes. On digital rectal examination, a hard nodule of the right prostate lobe was palpable. Serum PSA was 15.5 ng/ml. Scrotal ultrasound showed a 35 mm large cyst of the head of left epididymis, with normal appearing testicular parenchyma. A transrectal prostate biopsy was then performed, which revealed a Gleason grade 4 adenocarcinoma. A CT scan of the abdomen, a bone scan and a chest X-ray ruled out regional and distant metastases, and the patient underwent a retropubic radical prostatectomy with pelvic lymph node dissection. Histopathological examination with whole-mount section revealed an intracapsular, bilateral, Gleason score 9 adenocarcinoma of the prostate, with no invasion of regional lymph nodes. Serum PSA levels at 1 and 3 months after surgery were undetectable. At 6 months postoperatively, the patient presented with bilateral testicular pain. A scrotal ultrasound confirmed the previously diagnosed left spermatocele; in addition, a round, 10 mm, hypoechoic, heterogeneous, vascularized mass of the left testis was noticeable (Figure 1 ). Serum markers for testis cancer were within normal limits and serum PSA was still undetectable. No local recurrence of prostate cancer was evident. Since both primary and secondary malignancy were deemed very unlikely, given the patient's age and clinical history, and since the patient desired to preserve testicular tissue, an inguinal ultrasoundguided testis-sparing procedure was subsequently performed, with removal of the lesion and 2 mm normal appearing surrounding parenchyma. Macroscopically, the mass was brown in colour, well capsulated, with clear margins and no typical appearance of cancerous tissue, therefore, no intraoperative frozen sections were performed. Histologically, a poorly differentiated adenocarcinoma compatible with metastatic deposit from a prostatic primary was diagnosed. PSA staining was intensely positive (Figure 2 ). Metastatic work-up was again negative. After a follow-up of 12 months from testicular surgery, the patient is doing well with no biochemical, radiological and clinical sign of disease progression.
Discussion
Disease recurrence after radical prostatectomy occurs in approximately 35% of patients within 10 years following surgery. As a rule, clinical recurrence is anticipated by biochemical failure by a time interval of several years and the most frequent locations of distant relapse are bone, lung and liver. Once it has occurred, the prognosis is usually dismal. 4 The peculiarity of the present case is threefold. Firstly, a solitary metastasis developed from an organ-confined prostate cancer, while all the reports so far published included patients in whom the testicular involvement was part of a generalized disseminated disease, the prostatic primary being at an advanced stage. Secondly, the metastasis, albeit expressing PSA, was neither preceded by nor associated with biochemical failure. Very few cases of disease recurrence after radical prostatectomy with undetectable PSA have been described, including loco-regional and/or distant relapse. 5, 6 As pointed out in such reports, this fact may be explained considering that some prostatic primaries with high Gleason score have a low propensity to produce PSA. Thirdly, the interval between the radical treatment and the recurrence was quite short, approximately 6 months. This should stand for a highly aggressive disease, but up to 1 year of follow-up no new sign of progression became evident.
Furthermore, to the best of our knowledge, a testissparing surgery has never been performed, either intentionally or incidentally, in a case of metastatic prostate cancer. The short-term follow-up of our patient is promising, but longer observation time is needed to appropriately judge the oncological outcome.
In conclusion, based on the present report, we strongly advise that any intratesticular mass should be viewed as potentially malignant, irrespectively of the modality of presentation and regardless of the patient's age and previous clinical history. Testicular metastasis as isolated recurrence after radical prostatectomy F Menchini-Fabris et al
